Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update describes the RA-DRUM trial evaluating whether proactive therapeutic drug monitoring maintains disease control in adults with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Subcutaneous TNF inhibitor

Snippet

Sponsor: Diakonhjemmet Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING